Dupont Capital Management Corp Seagen Inc. Transaction History

Dupont Capital Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$117.37 - $139.17 $51,408 - $60,956	438 Added 34.11%	1,722 $0
Q3 2022 Oct 31, 2022	BUY	$135.27 - $180.11 $111,733 - $148,770	826 Added 180.35%	1,284 $176,000
Q2 2022 Jul 26, 2022	BUY	$108.81 - $179.33 $49,834 - $82,133	458 New	458 $81,000
Q1 2022 Apr 27, 2022	SELL	$119.61 - $157.85 $98,558 - $130,068	-824 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$142.57 - $190.86 $56,457 - $75,580	396 Added 92.52%	824 $127,000
Q3 2021 Nov 03, 2021	SELL	$142.45 - $169.82 $102,421 - $122,100	-719 Reduced 62.69%	428 $73,000
Q2 2021 Jul 30, 2021	BUY	$135.08 - $161.1 $154,936 - $184,781	1,147 New	1,147 $181,000
Q1 2021 Apr 29, 2021	SELL	$137.51 - $190.8 $290,421 - $402,969	-2,112 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$164.63 - $211.93 $347,698 - $447,596	2,112 New	2,112 $370,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.